DNA-Encoded Library Hit Confirmation: Bridging the Gap Between On-DNA and Off-DNA Chemistry.


Journal

ACS medicinal chemistry letters
ISSN: 1948-5875
Titre abrégé: ACS Med Chem Lett
Pays: United States
ID NLM: 101521073

Informations de publication

Date de publication:
08 Jul 2021
Historique:
received: 17 03 2021
accepted: 20 05 2021
entrez: 16 7 2021
pubmed: 17 7 2021
medline: 17 7 2021
Statut: epublish

Résumé

DNA-encoded library (DEL) technology is a powerful platform for hit identification in academia and the pharmaceutical industry. When conducting off-DNA resynthesis hit confirmation after affinity selection, PCR/sequencing, and data analysis, one typically assumes a "one-to-one" relationship between the DNA tag and the chemical structure of the attached small-molecule it encodes. Because library synthesis often yields a mixture, this approximation increases the risk of overlooking positive discoveries and valuable information. To address this issue, we apply a library synthesis "recipe" strategy for on-DNA resynthesis using a cleavable linker, followed by direct affinity selection mass spectrometry (AS-MS) evaluation and identification of binder(s) from the released small-molecule mixture. We validate and showcase this approach employing the receptor-interacting-protein kinase 2 (RIP2) DEL campaign. We also designed and developed two cleavable linkers to enable this method, a photocleavable linker (nitrophenyl-based) and acid-labile linker (tetrahydropyranyl ether). The strategy provides an effective means of hit identification and rapid determination of key active component(s) of the mixture.

Identifiants

pubmed: 34267887
doi: 10.1021/acsmedchemlett.1c00156
pmc: PMC8274064
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1166-1172

Informations de copyright

© 2021 American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Références

SLAS Discov. 2021 Feb;26(2):263-280
pubmed: 33412987
Bioorg Med Chem. 2021 Jul 1;41:116205
pubmed: 34000509
Mol Divers. 1995 Sep;1(1):4-12
pubmed: 9237189
ACS Comb Sci. 2015 Dec 14;17(12):722-31
pubmed: 26562224
J Health Econ. 2016 May;47:20-33
pubmed: 26928437
J Am Chem Soc. 2004 Dec 1;126(47):15495-503
pubmed: 15563178
Bioorg Med Chem. 2015 Nov 1;23(21):7000-6
pubmed: 26455654
ACS Med Chem Lett. 2018 Sep 26;9(10):1039-1044
pubmed: 30344914
Biol Chem. 2018 Jun 27;399(7):691-710
pubmed: 29894294
SLAS Discov. 2018 Oct;23(9):881-897
pubmed: 29874524
Nat Rev Drug Discov. 2017 Feb;16(2):131-147
pubmed: 27932801
J Med Chem. 2016 May 26;59(10):4867-80
pubmed: 27109867
J Med Chem. 2020 Jul 9;63(13):6578-6599
pubmed: 32039601
J Med Chem. 2020 Apr 9;63(7):3552-3562
pubmed: 32073266
Nat Chem Biol. 2009 Sep;5(9):647-54
pubmed: 19648931
ACS Med Chem Lett. 2021 Feb 11;12(3):343-350
pubmed: 33738060
Chembiochem. 2017 May 4;18(9):827-828
pubmed: 28318088
ACS Comb Sci. 2018 May 14;20(5):251-255
pubmed: 29648439
J Am Chem Soc. 2019 Feb 27;141(8):3723-3732
pubmed: 30753065
ACS Comb Sci. 2015 Jan 12;17(1):1-4
pubmed: 25459065
ACS Chem Biol. 2018 Jan 19;13(1):53-59
pubmed: 29185700
Nat Commun. 2017 Jul 17;8:16081
pubmed: 28714473
ACS Med Chem Lett. 2015 Mar 20;6(5):531-6
pubmed: 26005528
Bioconjug Chem. 2021 May 19;32(5):1001-1007
pubmed: 33914520
Trends Chem. 2021 Mar;3(3):161-175
pubmed: 33987530
J Med Chem. 2019 Jul 25;62(14):6482-6494
pubmed: 31265286

Auteurs

Bing Xia (B)

Encoded Library Technologies/NCE Molecular Discovery, R&D Medicinal Science and Technology, GlaxoSmithKline, 200 Cambridge Park Drive, Cambridge, Massachusetts 02140, United States.

G Joseph Franklin (GJ)

Encoded Library Technologies/NCE Molecular Discovery, R&D Medicinal Science and Technology, GlaxoSmithKline, 200 Cambridge Park Drive, Cambridge, Massachusetts 02140, United States.

Xiaojie Lu (X)

Encoded Library Technologies/NCE Molecular Discovery, R&D Medicinal Science and Technology, GlaxoSmithKline, 200 Cambridge Park Drive, Cambridge, Massachusetts 02140, United States.

Katie L Bedard (KL)

Encoded Library Technologies/NCE Molecular Discovery, R&D Medicinal Science and Technology, GlaxoSmithKline, 200 Cambridge Park Drive, Cambridge, Massachusetts 02140, United States.

LaShadric C Grady (LC)

Encoded Library Technologies/NCE Molecular Discovery, R&D Medicinal Science and Technology, GlaxoSmithKline, 200 Cambridge Park Drive, Cambridge, Massachusetts 02140, United States.

Jennifer D Summerfield (JD)

Encoded Library Technologies/NCE Molecular Discovery, R&D Medicinal Science and Technology, GlaxoSmithKline, 200 Cambridge Park Drive, Cambridge, Massachusetts 02140, United States.

Eric X Shi (EX)

Encoded Library Technologies/NCE Molecular Discovery, R&D Medicinal Science and Technology, GlaxoSmithKline, 200 Cambridge Park Drive, Cambridge, Massachusetts 02140, United States.

Bryan W King (BW)

Encoded Library Technologies/NCE Molecular Discovery, R&D Medicinal Science and Technology, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States.

Kenneth E Lind (KE)

Encoded Library Technologies/NCE Molecular Discovery, R&D Medicinal Science and Technology, GlaxoSmithKline, 200 Cambridge Park Drive, Cambridge, Massachusetts 02140, United States.

Cynthia Chiu (C)

Encoded Library Technologies/NCE Molecular Discovery, R&D Medicinal Science and Technology, GlaxoSmithKline, 200 Cambridge Park Drive, Cambridge, Massachusetts 02140, United States.

Eleanor Watts (E)

Encoded Library Technologies/NCE Molecular Discovery, R&D Medicinal Science and Technology, GlaxoSmithKline, 200 Cambridge Park Drive, Cambridge, Massachusetts 02140, United States.

Vera Bodmer (V)

Encoded Library Technologies/NCE Molecular Discovery, R&D Medicinal Science and Technology, GlaxoSmithKline, 200 Cambridge Park Drive, Cambridge, Massachusetts 02140, United States.

Xiaopeng Bai (X)

Encoded Library Technologies/NCE Molecular Discovery, R&D Medicinal Science and Technology, GlaxoSmithKline, 200 Cambridge Park Drive, Cambridge, Massachusetts 02140, United States.

Lisa A Marcaurelle (LA)

Encoded Library Technologies/NCE Molecular Discovery, R&D Medicinal Science and Technology, GlaxoSmithKline, 200 Cambridge Park Drive, Cambridge, Massachusetts 02140, United States.

Classifications MeSH